Table 1.
Study population
| Latent Mtb N = 14 | Latent Mtb DM N = 12 | Active TB N = 20 | Active TB DM N = 8 | |||
|---|---|---|---|---|---|---|
| N (%)/median (IQR) | p value | N (%)/median (IQR) | p value | |||
| Age | 35 (10) | 45 (27) | <0.001 | 28 (11) | 57 (7) | <0.001 |
| Male sex | 10 (71) | 5 (42) | 0.13 | 17 (85) | 7 (88) | 0.86 |
| Low socio‐economic status | 3 (23) | 2 (17) | 0.69 | 7 (37) | 3 (43) | 0.78 |
| Body mass index (kg/m2) | 23.4 (5.5) | 26.3 (8.8) | 0.96 | 18.4 (4.3) | 18.7 (3.6) | 0.57 |
| Under treatment for diabetes | – | 12 (100) | – | – | 5 (63) | – |
| TB symptom duration >1month | – | – | – | 15 (79) | 6 (86) | 0.70 |
| Fasting capillary glucose (mmol/L) | 4.8 (0.7) | 10.1 (4.6) | <0.001 | 5.0 (0.5) | 18.3 (12) | <0.001 |
| Fasting plasma glucose (mmol/L) | 5.1 (1.1) | 16.4 (4.6) | <0.001 | 5.1 (0.6) | 20.7 (6.2) | <0.001 |
| Glycated Hemoglobin (%) | 5.4 (0.6) | 11.2 (3.4) | <0.001 | 5.8 (0.7) | 13.6 (4.5) | <0.001 |
Latent Mtb: Mycobacterium tuberculosis latent infection defined as positive Mtb‐specific Interferon‐Gamma enzyme‐linked immunospot assay or positive Mtb‐specific flow cytometry response/TB: tuberculosis/DM: diabetes mellitus. p value calculated with two‐sided Wilcoxon–Mann–Whitney or chi‐square tests when appropriate.